[Form 4] PROCTER & GAMBLE Co Insider Trading Activity

Rhea-AI Filing Summary

Procter & Gamble (PG) reported a director equity award. On 10/14/2025, Director Robert Portman acquired 1,475 shares of common stock at a price of $0, indicated as restricted stock units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

Following this grant, Portman beneficially owns 4,894.5944 shares, held directly. This filing reflects routine director compensation through equity and does not indicate any open‑market purchase or sale.

Insights

Corporate governance analyst

Routine director RSU grant; minimal investment impact.

PG disclosed a director grant of 1,475 shares at $0 on 10/14/2025, tied to the company’s 2019 Stock and Incentive Compensation Plan. The footnote identifies these as restricted stock units.

This is standard board compensation and does not represent a market transaction. Beneficial ownership after the award is 4,894.5944 shares, held directly by the director.

As a routine compensation event, market impact is typically limited; any effect depends on future vesting and holding decisions not detailed in the excerpt.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Portman Robert Jones

(Last) (First) (Middle)

ONE PROCTER & GAMBLE PLAZA

(Street)

CINCINNATI OH 45202

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PROCTER & GAMBLE Co [ PG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/14/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/14/2025		A		1,475	A	$0(1)	4,894.5944	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.

	/s/ Wednesday Shipp, attorney-in-fact for Robert Portman	10/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Procter & Gamble (PG) disclose in this Form 4?

A director acquired 1,475 shares at $0 on 10/14/2025 via restricted stock units under the 2019 plan.

Who is the reporting person in PG’s Form 4?

Director Robert Portman, as indicated by the signature line from an attorney-in-fact.

How many PG shares does the director own after the transaction?

Beneficial ownership is 4,894.5944 shares, held directly.

Was this an open-market transaction for PG stock?

No. It reflects an equity award at $0, noted as restricted stock units under the 2019 plan.

What is the transaction date in PG’s filing?

10/14/2025.

What plan governs the equity award disclosed by PG?

The Procter & Gamble 2019 Stock and Incentive Compensation Plan.